{"id":"W3095552675","doi":"10.1200/jco.20.01632","title":"Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; Agence Nationale de la Recherche; National Cancer Institute; Medical Research Council; National Institute for Health and Care Research; Agios Pharmaceuticals","keywords":"Medicine; Internal medicine; Neutropenia; Myeloid leukemia; Adverse effect; Gastroenterology; Azacitidine; Isocitrate dehydrogenase; Oncology; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000380038,0.000315596,0.001015265,0.0002416128,0.0001855809,0.0003482111,0.0003358827,0.0002241871,0.0009251831],"category_scores_gemma":[0.0004160487,0.0001384489,0.0003264902,0.0002165178,0.000220772,0.0001936918,0.0002310846,0.0007320961,0.0001665573],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005345696,"about_ca_system_score_gemma":0.0004960854,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005196218,"about_ca_topic_score_gemma":0.003141946,"domain_scores_codex":[0.999818,0.00007505892,0.00002086119,0.0000300739,0.00002783462,0.00002807627],"domain_scores_gemma":[0.99981,0.00003732626,0.0000500659,0.0000145513,0.000009584184,0.00007853452],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1535371,0.008639066,0.05201213,0.001919751,0.001235044,0.001664534,0.0004800707,0.004868933,0.1600987,0.0006540204,0.003992333,0.6108983],"study_design_scores_gemma":[0.1225823,0.4313489,0.2635174,0.0008172626,0.003254915,0.009349949,0.0004189987,0.01014478,0.0972067,0.001104104,0.06011049,0.0001441769],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9821227,0.01340993,0.0007173212,0.0002252904,0.0001024024,0.0004853634,0.0002308914,0.00005913939,0.002647074],"genre_scores_gemma":[0.9949182,0.003042443,0.0008458988,0.0001343819,0.00005552857,0.0001644695,0.0002570481,0.000004999888,0.0005771704],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001015265,"threshold_uncertainty_score":0.003878534,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08517720452467968,"score_gpt":0.4167741424278661,"score_spread":0.3315969379031864,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}